Transchem Ltd

Transchem Ltd (TRANSCHEM) is a micro-cap Healthcare company valued at ₹507 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Transchem Ltd last traded at ₹414.85, modestly up 0.10% on the day.

Recent developments

On 2026-06-30, the company reported a net profit of ₹3 crore for the latest quarter, up from ₹1 crore in the same quarter a year earlier. The company's promoter holding remained at 56.45% as of 2026-06-30, with no significant changes in foreign or domestic institutional holdings.

Financial performance

The company's business has shifted from mushroom manufacturing to financial services, with no revenue or profit from operations. Net profit rose sharply in the latest quarter, up 245.5% year-over-year to ₹3 crore, but annual net profit remains at ₹4 crore. Return on equity and return on capital employed are low at 5.1% and 6.7%, respectively.

Valuation multiples

The stock trades at 118.2 times earnings, a premium to the Healthcare median of 32.0, 5.56 times book value.

Things to watch

The company has no revenue from its core operations, relying instead on inter-corporate deposits and treasury investments. Net profit in the latest quarter was significantly higher than the previous year, but annual net profit is only ₹4 crore. The stock is 4.1% below its 52-week high.

Where it stands

Transchem Ltd's business is based on financial services with no operational revenue. The latest quarter saw a sharp rise in net profit, but annual figures remain low. The stock is trading at 4.1% below its 52-week high, and the company is almost debt-free.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.